Connor Clark & Lunn Investment Management Ltd. Makes New Investment in Avantor, Inc. $AVTR

Connor Clark & Lunn Investment Management Ltd. bought a new position in shares of Avantor, Inc. (NYSE:AVTR) in the second quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm bought 388,392 shares of the company’s stock, valued at approximately $3,845,000. Connor Clark & Lunn Investment Management Ltd. owned approximately 0.06% of Avantor as of its most recent filing with the Securities & Exchange Commission.

A number of other institutional investors also recently modified their holdings of the business. Private Management Group Inc. lifted its position in shares of Avantor by 50.4% during the 4th quarter. Private Management Group Inc. now owns 2,456,859 shares of the company’s stock worth $28,156,000 after buying an additional 823,572 shares during the last quarter. GSA Capital Partners LLP acquired a new stake in Avantor during the 2nd quarter worth $800,000. Oppenheimer Asset Management Inc. purchased a new stake in Avantor in the second quarter valued at $805,000. Assenagon Asset Management S.A. lifted its position in Avantor by 425.0% in the second quarter. Assenagon Asset Management S.A. now owns 556,871 shares of the company’s stock valued at $5,513,000 after acquiring an additional 450,801 shares during the last quarter. Finally, Brickwood Asset Management LLP boosted its stake in Avantor by 6,891.9% in the fourth quarter. Brickwood Asset Management LLP now owns 3,184,043 shares of the company’s stock valued at $36,489,000 after acquiring an additional 3,138,504 shares in the last quarter. Institutional investors own 95.08% of the company’s stock.

Avantor Stock Down 0.1%

Avantor stock opened at $14.60 on Friday. Avantor, Inc. has a twelve month low of $7.26 and a twelve month high of $15.93. The stock has a 50 day moving average of $12.12 and a two-hundred day moving average of $9.77. The company has a current ratio of 1.78, a quick ratio of 1.18 and a debt-to-equity ratio of 0.65. The stock has a market capitalization of $9.87 billion, a price-to-earnings ratio of -17.38, a PEG ratio of 11.03 and a beta of 0.89.

Avantor (NYSE:AVTR) last released its earnings results on Wednesday, July 29th. The company reported $0.21 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.19 by $0.02. Avantor had a positive return on equity of 9.92% and a negative net margin of 8.81%.The business had revenue of $1.69 billion for the quarter, compared to analyst estimates of $1.61 billion. During the same quarter in the previous year, the company posted $0.24 earnings per share. The company’s revenue for the quarter was up .5% compared to the same quarter last year. Avantor has set its FY 2026 guidance at 0.800-0.830 EPS. As a group, research analysts expect that Avantor, Inc. will post 0.81 earnings per share for the current year.

Analyst Ratings Changes

A number of analysts have recently commented on the company. Jefferies Financial Group upgraded Avantor from an “underperform” rating to a “hold” rating and set a $13.00 target price on the stock in a research report on Wednesday, July 29th. Sanford C. Bernstein initiated coverage on Avantor in a research note on Friday, June 26th. They set a “market perform” rating and a $10.50 price target on the stock. Barclays lifted their price target on Avantor from $7.00 to $8.00 and gave the stock an “underweight” rating in a research report on Wednesday, June 24th. Royal Bank Of Canada raised their target price on shares of Avantor from $9.00 to $14.00 and gave the stock a “sector perform” rating in a research report on Thursday, July 30th. Finally, UBS Group set a $8.00 price target on shares of Avantor in a research report on Wednesday, June 24th. Two equities research analysts have rated the stock with a Buy rating, fifteen have given a Hold rating and one has issued a Sell rating to the company’s stock. According to data from MarketBeat.com, the company presently has a consensus rating of “Hold” and a consensus target price of $12.00.

About Avantor

Avantor, Inc (NYSE:AVTR) is a global provider of mission-critical products and services to customers in the biopharma, healthcare, education & government, and advanced technologies & applied materials industries. The company delivers essential solutions that support research, development, production and safety applications. Its product portfolio spans from high-purity chemicals and reagents to biologics and cell culture media, as well as lab equipment, consumables and custom manufacturing services.

Avantor’s offerings are organized across two primary segments.